| Typicality: | 0.540 |
| Saliency: | 0.386 |
| continually | 25 | temporal |
| more closely | 8 | degree |
| than other highly regulated drugs | 4 | other |
| vaccine → be monitored for → safety | 27 |
| vaccine → be → monitored | 21 |
| vaccine → have → ongoing safety monitoring | 3 |
| negative | neutral | positive |
| 0.140 | 0.691 | 0.169 |
| Raw frequency | 51 |
| Normalized frequency | 0.386 |
| Modifier score | 0.888 |
| Perplexity | 41.713 |